Form 4: Director McCormick Exercises Options in Inspire Medical Systems
SEC Form 4 Filing
Shawn McCormick, a director at Inspire Medical Systems, exercised stock options and acquired shares on May 10, 2024.
Summary
- On May 10, 2024, Shawn McCormick, a director of Inspire Medical Systems, exercised stock options to acquire 2,500 shares of common stock at a price of $0.94 per share.
- Following the transaction, McCormick directly owns 15,403 shares of common stock.
- McCormick also indirectly owns 3,000 shares through a trust.
- He also holds 1,019 stock options.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock option exercises. It doesn't inherently convey strong positive or negative sentiment.
Positives
- The exercise of options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure related to insider transactions and doesn't necessarily reflect broader industry trends.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the issuance of new shares through option exercise.
Key Dates
| Date | Description |
|---|---|
| 01/01/2027 | Expiration date of stock options |
| 05/10/2024 | Date of transaction: McCormick exercised stock options. |
| 05/13/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.